Magnesium oxide and Gemtesa drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Magnesium oxide (magnesium) and Gemtesa (vibegron). Common drug interactions include acne among females and cataplexy among males.
The phase IV clinical study analyzes what interactions people have when they take Magnesium oxide and Gemtesa. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Magnesium oxide?
Magnesium oxide has active ingredients of magnesium. It is often used in migraine. eHealthMe is studying from 19,022 Magnesium oxide users. Check the latest studies of Magnesium oxide.
What is Gemtesa?
Gemtesa has active ingredients of vibegron. eHealthMe is studying from 2,648 Gemtesa users. Check the latest studies of Gemtesa.
13 people who take Magnesium oxide and Gemtesa together, and have interactions are studied.

What are the common drug interactions of Magnesium Oxide and Gemtesa, by gender? *:
female:
- Acne (skin problems that cause pimples)
- Drug ineffective
- Dry mouth
- Scab (a hard coating on the skin formed during the wound healing)
- Abdominal pain lower
- Accident
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Chronic kidney disease
- Drug hypersensitivity
- Dysuria (painful or difficult urination)
male:
- Cataplexy (loss of muscle tone accompanied by full conscious awareness)
- Fall
- Prostatic haemorrhage (bleeding from prostate)
- Prostatomegaly (enlargement of the prostate)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Wound haemorrhage (bleeding wound)
- Bladder hypertrophy (bladder overgrowth- increase in cell size)
- Bladder outlet obstruction (urological condition where the urine flow from the urinary bladder through the urethra is impeded)
- Contusion (a type of hematoma of tissue in which capillaries)
- Death
What are the common drug interactions of Magnesium Oxide and Gemtesa, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Acne (skin problems that cause pimples)
- Scab (a hard coating on the skin formed during the wound healing)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Drug ineffective
- Dry mouth
- Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
- Hypersensitivity
- Lacrimation increased
- Rash
- Rash pruritic (redness with itching)
50-59:
- Drug hypersensitivity
- Hypersomnia (excessive daytime sleepiness (eds))
- Sinusitis (inflammation of sinus)
60+:
- Accident
- Chronic kidney disease
- Prostatic haemorrhage (bleeding from prostate)
- Prostatomegaly (enlargement of the prostate)
- Renal failure (kidney dysfunction)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Wound
- Wound haemorrhage (bleeding wound)
- Wound infection
- Contusion (a type of hematoma of tissue in which capillaries)
What are the existing conditions these people have? *
- Drowsiness: 2 people, 15.38%
- Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 15.38%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 15.38%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 15.38%
- Dyspnea (difficult or laboured breathing): 1 person, 7.69%
- Gout (uric acid crystals building up in the body): 1 person, 7.69%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%
- Fungal Infection: 1 person, 7.69%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 7.69%
- Erection Problems: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Magnesium oxide and Gemtesa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Magnesium oxide (19,022 reports)
- Gemtesa (2,648 reports)
Browse all drug interactions of Magnesium oxide and Gemtesa:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Magnesium oxide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Gemtesa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Magnesium oxide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gemtesa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on magnesium and vibegron (the active ingredients of Magnesium oxide and Gemtesa, respectively), and Magnesium oxide and Gemtesa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Diflucan and Stevens Johnson Syndrome for Women aged 60+ - a second ago
- Diflucan and Sjs for Women aged 60+ - a second ago
- Diflucan and Toxic Epidermal Necrolysis for Women aged 60+ - a second ago
- Diflucan and Stevens-Johnson Syndrome for Women aged 60+ - 2 seconds ago
- Diflucan and Lyell'S Syndrome for Women aged 60+ - 2 seconds ago
- Diflucan and Erythema Multiforme for Women aged 60+ - 2 seconds ago
- Drug interactions of Epidiolex and Morphine - 9 seconds ago
- Skin Swelling and drugs of ingredients of donepezil hydrochloride - 19 seconds ago
- Could Valproic Acid cause Immunodeficiency Disorders? - 21 seconds ago
- Tecfidera and Appetite - Decreased for Men aged 20-29 - 33 seconds ago